(Plainsboro, New Jersey — August 15, 2024) dsm-firmenich Animal Nutrition and Health — a global science-based company focused on nutrition, health and sustainable living — announced the Canadian Food Inspection Agency (CFIA) approval of a novel enzyme, fumonisin esterase, to help swine and poultry producers manage mycotoxins in feed.

dsm-firmenich will offer a new product which includes the fumonisin esterase called Mycofix^® FUMzyme^® for use in swine and poultry diets in Canada. More information will be available in the coming weeks.

Paige Gott, Ph.D., dsm-firmenich Strategic Product Manager, said, “Fumonisin esterase is for the degradation of fumonisins present in swine and poultry feed. This approval expands dsm-firmenich’s commitment to innovation in mycotoxin risk management.”

“This will be the first product ever to be approved for degrading fumonisins in feed in the Canadian market,” said Gott. “Mycotoxins can have various negative effects on swine and poultry production. Fumonisins are the second most prevalent group of mycotoxins worldwide. Fumonisins are commonly found in livestock diets in North America and can interact with other mycotoxins and have synergistic effects that impair health and productivity of livestock and poultry. They are of increasing importance with more frequent extreme weather events in the region.”

Customers interested in learning more about mycotoxin solutions should contact their dsm-firmenich representative or visit the Mycofix FUMzyme webpage.